Loading candles…
Alkem Laboratories Ltd. is a pharmaceutical and nutraceutical company operating globally with a presence spanning over 50 years. It is engaged in research, development, manufacturing, and marketing across the pharmaceutical value chain. The company produces a range of products including pharmaceutical and nutraceutical products, branded generics, complex generics, and biosimilars. Alkem holds a dominant market position in acute therapy areas, particularly in anti-infectives, where it has maintained leadership for more than 15 years. It is recognized as the fifth-largest pharmaceutical company in India. No information on incorporation details, founders, key management, subsidiaries, or stock exchange listings is available.
| Type | Details | Date |
|---|---|---|
| Audited Results - Q4 & FY26 | Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 28th May, 2026, inter alia:(i) To consider and approve the Standalone a… | 28 May 2026 |
| Other | Notice of meeting of the Board of Directors of Alkem Laboratories Limited ( the Company ) | 13 Feb 2026 |
| Unaudited Results - Q2 & FY25 | Notice of meeting of the Board of Directors of the Company scheduled to be held on Thursday, 13th November, 2025, inter alia, to consider and approve the Sta… | 13 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and final dividend, if any | 29 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.